Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Total Non-Current Liabilities (2017 - 2025)

Bioceres Crop Solutions' Total Non-Current Liabilities history spans 8 years, with the latest figure at $499.9 million for Q2 2024.

  • For Q2 2024, Total Non-Current Liabilities rose 2.72% year-over-year to $499.9 million; the TTM value through Jun 2024 reached $499.9 million, up 2.72%, while the annual FY2024 figure was $499.9 million, 2.72% up from the prior year.
  • Total Non-Current Liabilities for Q2 2024 was $499.9 million at Bioceres Crop Solutions, up from $486.7 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $499.9 million in Q2 2024 and bottomed at $106.2 million in Q2 2020.
  • The 5-year median for Total Non-Current Liabilities is $137.3 million (2022), against an average of $273.3 million.
  • The largest annual shift saw Total Non-Current Liabilities rose 0.73% in 2022 before it surged 254.57% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $106.2 million in 2020, then rose by 28.31% to $136.3 million in 2021, then increased by 0.73% to $137.3 million in 2022, then soared by 254.57% to $486.7 million in 2023, then increased by 2.72% to $499.9 million in 2024.
  • Per Business Quant, the three most recent readings for BIOX's Total Non-Current Liabilities are $499.9 million (Q2 2024), $486.7 million (Q2 2023), and $137.3 million (Q2 2022).